HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balloon catheter dilation as the primary treatment of congenital nasolacrimal duct obstruction.

AbstractPURPOSE:
The aim of this study is to report the outcome of balloon catheter dilation as the primary treatment of congenital nasolacrimal duct obstruction in children of all ages.
METHODS:
A 10-year retrospective study of 148 children (270 eyes), aged 9 to 159 months (mean age: 29.6 ± 17.7 months), who previously had not undergone a nasolacrimal surgical procedure and who presented with clinical signs of nasolacrimal duct obstruction, was conducted. All children underwent balloon catheter dilation of the nasolacrimal duct.
RESULTS:
Treatment success, defined as complete resolution of nasolacrimal duct obstruction symptoms present at follow-up visits at 1 week and up to 6 months after surgery, was 87% (234 of 270 eyes). Partial success was defined as occasional tearing which was acceptable to parents and present in 3% (nine eyes). Only 10% of the children underwent a second procedure due to complete failure. In a sub-analysis by age groups-under 18 months, between 18 and 36 months, and above 36 months-complete resolution rates were 85%, 93%, and 77%, and partial success rates were 3%, 3%, and 4%, respectively. There was a statistically significant difference between the age groups (p = .007).
CONCLUSION:
In this large cohort of patients with nasolacrimal duct obstruction, balloon catheter dilation was successful as a primary treatment for congenital nasolacrimal duct obstruction, particularly under the age of 36 months.
AuthorsInbal Gazit, Eran Pras, Lior Or, Morris E Hartstein
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) Vol. 31 Issue 2 Pg. 334-339 (Mar 2021) ISSN: 1724-6016 [Electronic] United States
PMID31888382 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Catheterization (methods)
  • Child
  • Child, Preschool
  • Dacryocystorhinostomy (methods)
  • Female
  • Humans
  • Infant
  • Intubation (methods)
  • Lacrimal Duct Obstruction (congenital, therapy)
  • Male
  • Nasolacrimal Duct (abnormalities)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: